Clinical and public health measures to cope with respiratory syncytial virus infection

PMC · DOI:10.2478/abm-2025-0014·June 30, 2025

Clinical and public health measures to cope with respiratory syncytial virus infection

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Species2

Homo sapiens(human · species)Respiratory syncytial virus(no rank)

Chemicals3

RSVpreF oxygen nirsevimab

Diseases14

influenza hypoxemia asthma crackles respiratory tract illness respiratory failure RSV COVID-19 respiratory distress bronchiolitis infection congestion rhinorrhea respiratory tract infection

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsRespiratory viral infections research · Viral Infections and Vectors